CLORINDA SHORES: Open Payments
NPI 1689885931 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 38 payments from 15 companies in 2025. Trend: 2023 $1,088 · 2024 $697 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $209 |
| AstraZeneca Pharmaceuticals LP | 6 | $196 |
| Abbott Laboratories | 5 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Corcept Therapeutics | 2 | $34 |
| ABBVIE INC. | 1 | $31 |
| Alkermes, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: BREZTRI, FREESTYLE LIBRE 3, Wegovy, AIRSUPRA, XIFAXAN, Rybelsus, GEMTESA, Ozempic.
Industry payments across CA — which companies pay providers there.
